EPHEDRINE SULFATE

Generic: EPHEDRINE SULFATE

Baxter Healthcare CorporationManufacturer
INTRAVENOUSRoute
EPHEDRINE SULFATEActive Substance
2026-07-08Original Approval

EPHEDRINE SULFATE is FDA application ANDA216740, sponsored by BAXTER HLTHCARE CORP. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
15 reports
2
CARDIAC ARREST
13 reports
3
TOXICITY TO VARIOUS AGENTS
13 reports
4
DRUG ABUSE
12 reports
5
OVERDOSE
12 reports
6
RESPIRATORY ARREST
11 reports
7
ADMINISTRATION RELATED REACTION
10 reports
8
HYPOTENSION
10 reports
9
OFF LABEL USE
10 reports
10
DRUG HYPERSENSITIVITY
9 reports